Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Alexion Pharm Inc (ALXN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 27,124,976
  • Shares Outstanding, K 222,500
  • Annual Sales, $ 3,551 M
  • Annual Income, $ 443,300 K
  • 36-Month Beta 1.11
  • Price/Sales 7.44
  • Price/Cash Flow 15.13
  • Price/Book 2.97

Price Performance

See More
Period Period Low Period High Performance
1-Month
114.36 +8.88%
on 05/29/18
124.77 -0.20%
on 06/20/18
+3.45 (+2.85%)
since 05/18/18
3-Month
102.10 +21.96%
on 04/20/18
124.77 -0.20%
on 06/20/18
+4.30 (+3.58%)
since 03/20/18
52-Week
102.10 +21.96%
on 04/20/18
149.34 -16.62%
on 09/05/17
+5.47 (+4.59%)
since 06/20/17

Most Recent Stories

More News
Alexion (ALXN) Submits Application for ALXN1210 with FDA

Alexion Pharmaceuticals, Inc. (ALXN) submits a Biologics License Application (BLA) to the FDA for approval of ALXN1210 to treat patients with paroxysmal nocturnal hemoglobinuria (PNH).

AGLE : 10.78 (-0.37%)
ILMN : 287.65 (+0.67%)
ANIP : 67.96 (+1.13%)
ALXN : 124.52 (+2.14%)
Look for Shares of Alexion Pharm to Potentially Pullback after Yesterday's 1.77% Rise

Alexion Pharm (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $121.86 to a high of $124.26. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of...

ALXN : 124.52 (+2.14%)
Sarepta Pharma Pushes Two Biotech ETFs to New Highs

The encouraging early trial results for a gene therapy for Duchenne muscular dystrophy pushed Sarepta Therapeutics and few biotech ETFs to new highs.

BBP : 46.17 (+2.24%)
SLDB : 35.67 (-17.05%)
BBC : 35.38 (+1.33%)
SBIO : 39.26 (+1.68%)
SRPT : 153.69 (+6.78%)
IBB : 113.90 (+1.66%)
VRTX : 157.63 (+2.03%)
ALNY : 105.26 (+0.61%)
XBI : 101.15 (+2.33%)
ALXN : 124.52 (+2.14%)
BIIB : 296.86 (+1.65%)
Biotech Stock Roundup: SRPT & SLDB Soar on Positive Data, ANIK & ZIOP Crash

The biotech sector showed volatility with a few companies gaining on positive data readouts while a few plunging on dismal results.

ANIK : 28.77 (-37.62%)
SLDB : 35.67 (-17.05%)
SRPT : 153.69 (+6.78%)
ZIOP : 3.60 (+5.88%)
AMGN : 186.51 (+0.17%)
ALXN : 124.52 (+2.14%)
Sarepta Pharma Pushes Two Biotech ETFs to New Highs

The encouraging early trial results for a gene therapy for Duchenne muscular dystrophy pushed Sarepta Therapeutics and few biotech ETFs to new highs.

BBP : 46.17 (+2.24%)
SLDB : 35.67 (-17.05%)
BBC : 35.38 (+1.33%)
SBIO : 39.26 (+1.68%)
SRPT : 153.69 (+6.78%)
IBB : 113.90 (+1.66%)
VRTX : 157.63 (+2.03%)
ALNY : 105.26 (+0.61%)
XBI : 101.15 (+2.33%)
ALXN : 124.52 (+2.14%)
BIIB : 296.86 (+1.65%)
Alexion Submits Application for Priority Review and Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the U.S.

-- Submission in the European Union on Track for Mid-Year and in Japan for the Second Half of the Year --

ALXN : 124.52 (+2.14%)
Alexion Announces Selection of Positive Phase 3 Clinical Data for ALXN1210 in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) for Late-Breaking Oral Presentation at Annual Conference of the European Hematology Association (EHA)

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that positive results from one of the two large Phase 3 studies of ALXN1210, the Company's investigational long-acting C5 complement...

ALXN : 124.52 (+2.14%)
Biotech Stock Roundup: AXON Soars, Amgen Drugs Get FDA, EC Nod

Key areas of focus in the biotech space include regulatory approvals and licensing/acquisition deals.

AXON : 2.82 (-2.76%)
REGN : 336.93 (+3.01%)
AMGN : 186.51 (+0.17%)
ALXN : 124.52 (+2.14%)
BIIB : 296.86 (+1.65%)
Wired News - Alexion Pharma and Complement Pharma Inked Deal to Co-develop Preclinical C6 Complement Inhibitor CP010

Stock Monitor: Unity Biotechnology Post Earnings Reporting

ALXN : 124.52 (+2.14%)
Alexion-Complement Pharma Tie Up to Treat Neuro Disorders

Alexion (ALXN) teams up with Complement Pharma to co-develop its C6 inhibitor, CP010, for neurodegenerative disorders.

CELG : 79.77 (+0.42%)
HALO : 19.47 (+1.56%)
SNY : 39.44 (+0.74%)
ALXN : 124.52 (+2.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade ALXN with:

Business Summary

Alexion Pharmaceuticals, Inc. is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the innovation, development and commercialization of life-changing therapies. Alexion is the global leader in complement inhibition and has developed and commercializes...

See More

Key Turning Points

2nd Resistance Point 126.63
1st Resistance Point 125.57
Last Price 124.52
1st Support Level 122.66
2nd Support Level 120.81

See More

52-Week High 149.34
Fibonacci 61.8% 131.29
Fibonacci 50% 125.72
Last Price 124.52
Fibonacci 38.2% 120.15
52-Week Low 102.10

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar